Comparative aspects of selected psychoactive compounds: biogenic amines, monoamine oxidase inhibitors, and lysergic acid diethylamide.
D000818:Animals; D002490:Central Nervous System / Q000187:drug effects; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D004364:Pharmaceutical Preparations / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology*; D014714:Vertebrates / Q000187:drug effects
D008996:Monoamine Oxidase Inhibitors; D004364:Pharmaceutical Preparations; D012701:Serotonin; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D009638:Norepinephrine